| Purpose | Patients | Evaluations | Perceived Effectiveness |
|---|---|---|---|
| Diabetes type 2 | 8,578 | 265 | |
| Diabetes type 1 | 1,394 | 36 | |
| Cystic fibrosis-related diabetes | 11 | 3 | |
| General health | 9 | 3 | |
| Elevated blood sugar (hyperglycemia) | 7 | 1 |
Common side effects
| Side effect | Patients | Percentage |
|---|---|---|
| Low blood sugar (hypoglycemia) | 14 | |
| Weight gain | 11 | |
| Reactive hypoglycemia | 5 | |
| Nausea | 4 | |
| Burning pain at injection site | 3 | |
| Injection site pain | 3 |
Side effect severity
| Severity | Evaluations | Percentage |
|---|---|---|
| Severe | 3 | |
| Moderate | 21 | |
| Mild | 58 | |
| None | 220 |
Member evaluations
betesgirl12
evaluated on Dec 15, 2006
- Perceived effectiveness for diabetes type 1: Slight
- Side effects: Moderate
healthy12345
evaluated on Jun 11, 2011
- Perceived effectiveness for diabetes type 2: Slight
- Side effects: Mild
Jimum1
evaluated on Mar 15, 2010
- Perceived effectiveness for diabetes type 2: Moderate
- Side effects: None